Wells Fargo & Company Teva Pharmaceutical Industries LTD Put Options Transaction History

Wells Fargo & Company

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 13, 2023	BUY	$7.95 - $9.48 $1.99 Million - $2.37 Million	250,000 New	250,000 $2.28 Million
Q4 2020 Feb 09, 2021	SELL	$8.61 - $11.04 $6.65 Million - $8.53 Million	-772,500 Reduced 79.43%	200,000 $185,000
Q1 2020 May 14, 2020	BUY	$6.69 - $13.45 $6.51 Million - $13.1 Million	972,500 New	972,500 $1.73 Million

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.